Abbott RALS Web3 Interface License and Device Connectivity

The Defense Health Agency issued a Notice of Intent to Sole Source Abbott RALS Web3 middleware software to Madigan Army Medical Center (MAMC) by August 7, 2026. Only Abbott holds the software authorization and Authority to Operate required to interface with the point-of-care testing instruments in use at MAMC; no competitors possess these credentials. The procurement justifies sole-source award under FAR Part 12 Commercial Acquisition based on exclusive licensing agreements and restrictive proprietary rights held by Abbott.

MAMC's Department of Pathology requires RALS Web3 to automate transfer of patient point-of-care test results from medical analyzers—including Nova Biomedical glucose meters, Abbott i-STATs, Siemens Clinitek Status, and Haemonetics TEG 6s devices—into patient Electronic Health Records. The software must manage bi-directional administrative oversight of certifications and re-certifications for approximately 1,000 testing personnel, track reagent expiration dates, conduct quality control testing, maintain critical results documentation, and comply with Defense Health Agency Information Security infrastructure requirements. Vendors may submit capability statements demonstrating compliance with the Performance Work Statement by the August 7 closing date.